Target intelligence / Profile preview

Gamma-secretase subunit PEN-2 (PEN-2)

Target
PEN-2
Molecular classification
Enzyme complex subunit, Other (gamma-secretase complex component)
01

Overview

Gamma-secretase subunit PEN-2 is an essential regulatory component of the gamma-secretase complex, a multi-subunit intramembrane protease responsible for cleaving type I transmembrane proteins such as the Notch receptor and amyloid precursor protein. The gene encoding this protein is PSENEN. As part of the gamma-secretase complex—alongside presenilin, nicastrin, and APH1—PEN‑2 is required for proper assembly and function of the enzyme. This activity is critical in pathways like Notch signaling that govern cell fate decisions during development. In addition to its role in neurodevelopmental processes, aberrant function or mutations in PEN‑2/PSENEN are associated with diseases including Alzheimer’s disease (via altered amyloid beta production) and certain skin disorders such as Dowling-Degos disease and familial acne inversa[1][5][8]. Recent research also indicates that metformin binds to PEN‑2 at therapeutic concentrations; this interaction may contribute to metformin's activation of AMPK through inhibition of v‑ATPase activity[1].

Other names
Presenilin enhancer protein 2PSENENPEN2presenilin enhancer gamma-secretase subunitMDS033
02

Mechanism of action

Modulation of gamma-secretase activity and proteolytic processing of substrates such as APP and Notch[1][5]

03

Biological functions

Proteolysis of transmembrane proteins (e.g., Notch, amyloid precursor protein)Regulation of Notch signaling pathway
04

Disease associations

Neurodegenerative disease (Alzheimer’s disease)Skin disorders (Dowling-Degos disease, familial acne inversa)
05

Interacting drugs

Metformin

Beyond the preview

Go deeper on Gamma-secretase subunit PEN-2 (PEN-2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gamma-secretase subunit PEN-2 (PEN-2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call